S-adenosylmethionine

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 1-6

  Mato, José M ^a   Lu, Shelly C ^b  

^a CIC BIOGUNE   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059722763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022079     Document Type: Chapter

References (17)

1. Finkelstein, J.D. Homocysteine: a history in progress. Nutr. Rev. 2000, 58 (7), 193–204.
2. Mato, J.M.; Corrales, F.J.; Lu, S.C.; Avila, M.A. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 2002, 16 (1), 15–26.
3. Lu, S.C.; Alvarez, L.; Huang, Z.Z.; Chen, L.X.; An, W.; Corrales, F.J.; Avila, M.A.; Kanel, G.; Mato, J.M. Methionine adenosyltransferase lA knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (10), 5560–5565.
4. Martínez-Chantar, M.L.; Corrales, F.J.; Martínez-Cruz, A.; García-Trevijano, E.R.; Huang, Z.Z.; Chen, L.X.; Kanel, G.; Avila, M.A.; Mato, J.M.; Lu, S.C. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 2002, 16 (10), 1292–1294.
5. Shivapurkar, N.; Poirier, L.A. Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methyl-deficient, amino aciddefined diets for one to five weeks. Carcinogenesis 1983, 4 (8), 1051–1057.
6. Koteish, A.; Diehl, A.M. Animal models of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16 (5), 679–690.
7. Schwahn, B.C.; Chen, Z.; Laryea, M.D.; Wendel, U.; Lussier-Cacan, S.; Genest, J., Jr.; Mar, M.H.; Zeisel, S.H.; Castro, C.; Garrow, T.; Rozen, R. Homocysteine–betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003, 17 (3), 512–514.
8. Santamaría, E.; Avila, M.A.; Latasa, M.U.; Rubio, A.; Martín-Duce, A.; Lu, S.C.; Mato, J.M.; Corrales, F.J. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U.S.A 2003, 100 (6), 3065–3070.
9. Duce, A.M.; Ortiz, P.; Cabrero, C.; Mato, J.M. S-Adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988, 8 (1), 65–68.
10. Avila, M.A.; Berasain, C.; Torres, L.; Martin-Duce, A.; Corrales, F.J.; Yang, H.P.; Prieto, J.; Lu, S.C.; Caballeria, J.; Rodes, J.; Mato, J.M. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 2000, 33 (6), 907–914.
11. Bottiglieri, T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside––molecular basis of a pleiotrophic molecule. Am. J. Clin. Nutr. 2002, 76 (5), 1151–1157.
12. Tsukamoto, H.; Lu, S.C. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 2001, 15 (8), 1335–1349.
13. Mato, J.M.; Alvarez, L.; Ortiz, P.; Pajares, M.A. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther. 1997, 73 (3), 265–280.
14. Pascale, R.M.; Simile, M.M.; DeMiglio, M.R.; Feo, F. Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol 2002, 27 (3), 193–198.
15. Agency for Healthcare Research and Quality. S-Adenosyl-L-methionine for Treatments of Depression, Osteoarthritis, and Liver Disease, Evidence Report=TechnologyAssessmentNo.64. http://www.ahrq.gov/clinic/tp-sametp.htm (accessed 2002).
16. Rambaldi, A.; Gluud, C. S-Adenosyl-L-methionine for alcoholic liver disease. Cochrane Database Syst. Rev. 2001, 4, CD002235.
17. Mato, J.M.; Cámara, J.; Fernández de Paz, J.; Caballería, L.; Coll, S.; Caballero, A.; García-Buey, L.; Beltrán, J.; Benita, V.; Caballería, J.; Solà, R.; Moreno-Otero, R.; Barrao, F.; Martin-Duce, A.; Correa, J.A.; Parés, A.; Barrao, E.; García-Magaz, I.; Puerta, J.L.; Moreno, J.; Boissard, G.; Ortiz, P.; Rodés, J. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized placebocontrolled, double-blind, multicentre trial. J. Hepatol. 1999, 30 (6), 1081–1089.